* Shockwave Medical Inc SWAV.OQ SWAV.O is expected
to show a
rise in quarterly revenue when it reports results on February
17.
* The Santa Clara California-based company is expected to
report
a 232.1% increase in revenue to $75.434 million from $22.72
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Shockwave Medical
Inc is
for earnings of 9 cents per share. For the same quarter last
year, the company reported a loss of 46 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Shockwave
Medical
Inc is $235, about 37.6% above its last closing price
of $146.57.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 -0.05 -0.06 0.05 Beat 187.5
Jun. 30 2021 -0.37 -0.40 -0.01 Beat 97.5
Mar. 31 2021 -0.46 -0.45 -0.68 Missed -52.2
Dec. 31 2020 -0.42 -0.42 -0.46 Missed -8.7
Sep. -0.56 -0.55 -0.38 Beat 31.3
30 2020
Jun. 30 2020 -0.63 -0.62 -0.56 Beat 9.9
Mar. 31 2020 -0.50 -0.49 -0.59 Missed -20
Dec. 31 2019 -0.51 -0.51 -0.49 Beat 3.5
This summary was machine generated February 15 at 21:20 GMT.
All figures in US dollars unless otherwise stated